Authors


Taylor Jones, PharmD, BCPS

Latest:

Influenza Vaccinations During the COVID-19 Pandemic

Given the collision of COVID-19 and flu season, receiving the flu vaccine may hold additional benefits by reducing symptoms that may be confused with those of the novel coronavirus.


Lisa Katzki, RN, BSN, PHN

Latest:

Emergency Preparedness: When Disaster Strikes

For patients who require life-sustaining medications, emergency preparedness is essential. Here is a game plan to guide you and your patients when facing the unexpected.



Jose Alvir, DrPH

Latest:

Impact of Co-Payment Discounts on Antidepressant Medication Adherence and Costs

A unique co-payment discount program for antidepressants was associated with higher antidepressant medication adherence, lower likelihood of discontinuation, and lower healthcare costs.


Adeola O. Grillo, PhD

Latest:

Optimization of Biopharmaceuticals

Pharmacists should be knowledgeable about the different approaches used to modify biopharmaceuticals and how they affect stability, dosing, safety, and efficacy.




Jerry A. Barbee Jr, PharmD, CPh

Latest:

CAR-NK Cell Immunotherapy Demonstrates Potential for Treating Patients With Relapsed or Refractory Lymphomas

Patients with relapsed/refractory leukemia and lymphomas generally have a grim prognosis, which has paved the way for immunotherapy treatments.


Michelle Sriprasert, MPH

Latest:

US Cost-Effectiveness of Saxagliptin in Type 2 Diabetes Mellitus

Saxagliptin, in combination with metformin, provides a durable, well-tolerated, and cost-effective treatment option for patients with type 2 diabetes mellitus, from a US payer perspective.


Joseph Barone, PharmD, BCOP

Latest:

Oncology Pharmacy Education Network: Finding Solutions Together

The Association of Community Cancer Centers (ACCC) Oncology Pharmacy Education Network (OPEN) provides resources that are pharmacist driven and developed.


Amy Lee, PharmD Candidate

Latest:

Dolutegravir Is Susceptible to Chelation-Type Interactions

Common medications containing polyvalent cations should be separated to prevent decreased absorption of the HIV therapy.


Richard Hillestad, PhD

Latest:

Comparative Effectiveness of Fidaxomicin for Treatment of Clostridium Difficile Infection

Our analysis models the clinical and economic value of fidaxomicin for the treatment of Clostridium difficile infection compared with metronidazole and vancomycin.



Allison M. Bell, PharmD, MSc, BCPS

Latest:

Patterns of Specific Testing for Patients With Chronic Myelogenous Leukemia

Study assessed chemotherapy use in patients with chronic myelogenous leukemia (CML) to determine how use of CML-specific tests impacted drug selection and modification.


Christopher S. Shain, PharmD, BCPS, Assistant Vice President, McKesson 340B Solutions

Latest:

Understanding and Navigating Specialty and Orphan Drug Challenges in the 340B Program

Failure to recognize the interests of manufacturers to ensure proper use of 340B pricing may result in 340B hospitals missing the opportunity to secure and retain discounts on key orphan and specialty drugs or may render them unable to access the drugs at all.


Lina Asmar, PhD

Latest:

Cost-Effectiveness of Docetaxel-Cyclophosphamide Versus Doxorubicin-Cyclophosphamide for Breast Cancer

Compared with doxorubicin plus cyclophosphamide, docetaxel plus cyclophosphamide was highly cost-effective for adjuvant treatment of operable breast cancer.



Jessica Langley

Latest:

Pharmacy Technicians to Play a Key Role in Upcoming Flu Season

On August 4, 2021, the Biden administration expanded the authority of pharmacy technicians under the PREP Act to allow pharmacy technicians to administer adult flu vaccines during the 2021-2022 flu season.


Jessica M. Ogburn, PharmD Candidate

Latest:

CANDOR Creates a Safer Health Care System

Now in 4 states, the program allows providers to admit errors without worry about legal ramifications in the courtroom.



By Dan Steiber, RPH, Specialty Pharmacy Times, Editor-in-Chief & Executive Vice President

Latest:

Finally Getting Real: Biosimilars

New guidelines and standards have facilitated a robust pipeline of biosimilars in the United States.


Donald Grove, RPh

Latest:

Pharmacy Work Flow: Improving Efficiency

Implementing a more efficient pharmacy system can have benefits for both patients and employees.



Suzanne A. Boren, PhD, MHA

Latest:

Taking Medication in Diabetes Self-Management: Issues and Recommendations for Reducing Barriers

This paper considers opportunities and barriers relating to medication taking and self-management by people with diabetes and related conditions as discussed during an invitational symposium.


Quintin Jesse, DPh

Latest:

Discover Nontraditional Pharmacy Practices from Industry to Specialty Pharmacy and More

Specialty pharmacies are molding the future of pharmacy and they offer the opportunity to practice clinical pharmacy. As you contemplate your next step, here are several nontraditional options available to you.



Caryn Domenici Belisle, RPh, Alka Patel, PharmD, Jennifer Platt, PharmD Candidate

Latest:

Sunovion Pharmaceuticals' Latuda

The FDA approved Sunovion Pharmaceuticals' Latuda (lurasidone HCL), an atypical antipsychotic used to treat schizophrenia in adults 18 years and older.



Annalisa Balini, MD

Latest:

Potential Gender Differences of Exenatide in Outpatients With Type 2 Diabetes Mellitus

In outpatients with type 2 diabetes mellitus, persistent exenatide treatment lowered glycated hemoglobin and hyperglycemia in both genders. Waist circumference and body weight were more reduced in women.


Rachel L. Basinger, PharmD, BCPS, CPP

Latest:

Alzheimer's Disease: Maximizing Cognition and Function

The decision to initiate treatment for Alzheimer's disease should be made with specific patient and caregiver goals in mind.